ZYUS Life Sciences Corporation
ZLSCF
$0.60
-$0.06-9.09%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.87M | -3.52M | -2.48M | -18.00M | -3.13M |
| Total Depreciation and Amortization | 528.60K | 531.30K | 534.80K | 599.00K | 566.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 203.10K | 146.90K | 155.80K | 14.44M | -111.10K |
| Change in Net Operating Assets | 1.04M | 2.51M | -171.30K | 888.70K | -3.74M |
| Cash from Operations | -1.10M | -323.70K | -1.96M | -2.07M | -6.42M |
| Capital Expenditure | -8.10K | 0.00 | -25.20K | -141.10K | -26.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.10K | 0.00 | -25.20K | -141.10K | -26.10K |
| Total Debt Issued | 300.00K | 400.00K | -- | 0.00 | 0.00 |
| Total Debt Repaid | -2.60M | -86.00K | -341.00K | -334.00K | -551.00K |
| Issuance of Common Stock | 3.31M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 744.90K | 229.50K | -252.90K | -245.50K | -410.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -359.30K | -94.30K | -2.23M | -2.46M | -6.85M |
